Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12151676.
- Also identified by PMC identifier 1742436.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Angioedema is a recognised side effect of rofecoxib, a cyclo-oxygenase-2 (COX-2) inhibitor. But death resulting from a haemorrhagic pulmonary oedema after its ingestion has not been recorded. The case of a 60 year old man who died from haemorrhagic pulmonary oedema in the presence of angioedema after the ingestion of two doses of 12.5 mg of rofecoxib is reported.
Medical subject headings
- Angioedema
- Anti-Inflammatory Agents, Non-Steroidal
- Cyclooxygenase Inhibitors
- Lactones
- Pulmonary Edema